We believe Genmab is in solid financial health. At the end of 2024, Genmab held DKK 9.9 billion in cash and cash equivalents. After turning profitable in 2013, the company has steadily increased its ...
Ongoing strategic partnership advances joint pipeline in neurodegeneration research• Evotec receives a $20 million payment to further progress research ...
Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Barchart on MSN14h
Is Bristol-Myers Stock Outperforming the Dow?Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, and markets ...
Bristol Myers Squibb is axing another 280 jobs as part of its $1.5 billion cost-cutting plan. The company is laying off 223 ...
As Bristol Myers Squibb rolls ahead with its plan to cut $1.5 billion in costs by the end of the year, the drugmaker is once ...
We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback